Neutralising antibodies to West Nile virus detected in horses in Windhoek, Namibia

West Nile virus (WNV) is a vector-borne virus maintained in nature by a bird-mosquito cycle. However, it can occasionally and accidentally infect horses and human beings, leading to sometimes severe or even fatal outcomes in these species. Therefore, the monitoring of its circulation and disease occ...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the South African Veterinary Association Vol. 93; no. 1; pp. 39a - 39c
Main Authors: Molini, U, Franzo, G, Rautenbach, I, Otto, HV, Khaiseb, S, Di Gennaro, A, Ntahonshikira, C, Baines, I, Monaco, F, Savini, G, D'alterio, N
Format: Journal Article
Language:English
Published: Medpharm Publications 01-01-2022
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:West Nile virus (WNV) is a vector-borne virus maintained in nature by a bird-mosquito cycle. However, it can occasionally and accidentally infect horses and human beings, leading to sometimes severe or even fatal outcomes in these species. Therefore, the monitoring of its circulation and disease occurrence is of relevance. Unfortunately, it is underdiagnosed or not diagnosed in several African counties, including Namibia, where no data is currently available for horses. In this study, 98 horses in three different stables in the Windhoek city area were investigated. They were found to have a seroprevalence of approximately 7%. Positive reactions were seen at all three stables, suggesting a greater than expected prevalence of the virus. This is the first report of serological evidence for the presence of the virus in horses in Nambia. Even though clinical signs were not reported in any of the stables from which the sera were derived, the seroprevalence to the virus suggests that horses with high genetic and/or economic value could benefit from vaccination against WNV. Because of the zoonotic potential of the virus, these findings are also of significance to human health authorities.
ISSN:1019-9128
2224-9435
DOI:10.36303/JSAVA.2022.93.1.165